Pancreatic tumor-induced gene may prove beneficial as a drug marker — ScienceDaily
source : http://www.sciencedaily.com/releases/2014/04/140428163643.htm
source : http://www.sciencedaily.com/releases/2014/04/140428163643.htm
source : http://www.sciencedaily.com/releases/2014/04/140417101454.htm
source : http://www.sciencedaily.com/releases/2014/03/140307111104.htm
source : http://www.sciencedaily.com/releases/2014/03/140302143659.htm
source : http://www.sciencedaily.com/releases/2014/02/140203131520.htm
source : http://www.sciencedaily.com/releases/2014/01/140129164646.htm
source : http://www.sciencedaily.com/releases/2014/01/140130164317.htm
source : http://www.sciencedaily.com/releases/2014/01/140128153812.htm
Such is the case with two proteins identified by scientists at The University of Texas MD Anderson Cancer Center that fit on to the same binding site on an important cellular growth factor receptor called FGFR2 with starkly different results. "There is competition for binding to FGFR2 and one of the two competitors, phospholipase Cγ1 (Plcγ1), will increase cancer cell metastasis. The other protein inhibits the opportunity for this to occur," said John Ladbury, Ph.D., professor of Biochemistry and Molecular Biology. …
"The mechanism behind the Kaposi’s sarcoma-associated herpesvirus (KSHV) that causes healthy cells to become malignant is not well understood despite two decades of intensive studies," said S. …